# Functional Dyspepsia: Validation of the Leuven Postprandial Distress Scale (LPDS) in a Placebo-controlled Trial

> **NCT04464369** · PHASE4 · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 105 (actual)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** itopride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04464369
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2020-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04464369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04464369, "Functional Dyspepsia: Validation of the Leuven Postprandial Distress Scale (LPDS) in a Placebo-controlled Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04464369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*